20
Chempacific Corp, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARMUSTINE DRUG SUBSTANCE, with a corresponding US DMF Number 22637.
Remarkably, this DMF maintains an Active status since its submission on March 20, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2017, and payment made on July 07, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II